Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.10
Delayed Data
As of Mar 03
 -0.11 / -4.98%
Today’s Change
1.00
Today|||52-Week Range
8.46
-17.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues33.1K5.0M3.8M8.0M
 
 
 
 
 
Depreciation And Amortization150.2K56.0K31.0K20.0K
 
 
 
 
 
 
Operating ExpensesGross Income-117.1K4.9M3.7M--
 
 
 
 
General Expenses21.3M30.8M38.3M39.7M
 
 
 
 
 
Research And Development14.4M22.6M29.2M28.9M
 
 
 
 
 
Total Operating Expenses21.4M30.9M38.4M39.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.4M-25.9M-34.6M-31.8M
 
 
 
 
 
Extraordinary Credit0.005.7M0.0096.0K
 
 
 
Extraordinary Charge0.000.00-7.5M--
 
 
Interest Expense On Debt0.00--1.9M2.9M
 
 
 
Other Expenses-3.2M0.0010.0K-4.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.6M-20.1M-44.0M-34.6M
 
 
 
 
 
Net Income-24.6M-20.1M-44.0M-34.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.9M46.4M48.1M52.2M
 
 
 
 
 
Shares To Calculate EPS Diluted24.9M46.4M48.1M52.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.94-$0.43-$0.91-$0.66
 
 
 
 
 
EPS Diluted-$1.02-$0.43-$0.91-$0.66
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account